You’re probably right about it only having a sho

You’re probably right about it only having a short term effect. In the end, the fundamentals prevail. Always.

Somehow I’m sure NP is going to surprise us with a debt financing arrangement that will make an end to all our quests for money.
I recall him saying something like the Chinese equity financing proposal being fair or good.
It’s off the table now, meaning there must be a better alternative.
In the CC NP used the term loan from a capital group (if I recall well, should listen again) related to the first $250 million revenue. I did not quite get that (it’s probably me).
Selling of Leronlimab for CCR5 testing purposes is quite a new development and is not dependent on FDA approval. With the focus shift on CCR5 that could lead to a substantial revenue stream, giving any lender more certainty.
Maybe that’s just what was needed to get us a loan.

NP was talking about being careful for the loyal shareholders.
Yes NP will get us a loan and that together with short term newsflow will lead to a paradigm shift in the investment community.
Cydy will be noticed and picked up. Soon.